24
Participants
Start Date
November 30, 2011
Primary Completion Date
December 31, 2014
Study Completion Date
February 28, 2015
Reveal XT® Insertable Cardiac Monitor
If not previously implanted, a non-experimental insertable cardiac monitor will be implanted to collect information on the patients' heart condition as inputs into the heart failure risk status algorithm (during guided follow-up only, Guided arm: 6-18 months, Control arm: 12-18 months).
Heart Failure Risk Status Diagnostic
"The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status and standard device trend data are provided to study doctors for remote management of their patients' heart failure using study specific protocols. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.~Based on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: Low, Medium, High, or Very High."
Lancaster Heart & Stroke Foundation, Lancaster
Carolinas Medical Center/Sanger Heart & Vascular, Charlotte
Medical University of South Carolina, Charleston
St. Thomas Research Institute, Nashville
The Ohio State University, Columbus
Spectrum Health, Grand Rapids
University of Texas Southwestern Medical Center, Dallas
Heart Clinic PLLC, McAllen
Aurora Denver Cardiology Associates, Aurora
Scripps Green, La Jolla
The Valley Hospital, Ridgewood
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY